<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.jcis.2022.03.036</dc:identifier><dc:language>eng</dc:language><dc:creator>Bonet-Aleta, Javier</dc:creator><dc:creator>Sancho-Albero, Maria</dc:creator><dc:creator>Calzada-Funes, Javier</dc:creator><dc:creator>Irusta, Silvia</dc:creator><dc:creator>Martin-Duque, Pilar</dc:creator><dc:creator>Hueso, Jose L.</dc:creator><dc:creator>Santamaria, Jesus</dc:creator><dc:title>Glutathione-Triggered catalytic response of Copper-Iron mixed oxide Nanoparticles. Leveraging tumor microenvironment conditions for chemodynamic therapy</dc:title><dc:identifier>ART-2022-128425</dc:identifier><dc:description>Heterogeneous catalysis has emerged as a promising alternative for the development of new cancer therapies. In addition, regarding the tumor microenvironment as a reactor with very specific chemical features has provided a new perspective in the search for catalytic nanoarchitectures with specific action against chemical species playing a key role in tumor metabolism. One of these species is glutathione (GSH), whose depletion is the cornerstone of emerging strategies in oncology, since this metabolite plays a pivotal regulatory role as antioxidant agent, dampening the harmful effects of intracellular reactive oxidative species (ROS). Herein, we present copper-iron oxide spinel nanoparticles that exhibit a versatile and selective catalytic response to reduce GSH levels while generating ROS in a cascade reaction. We demonstrate a clear correlation between GSH depletion and apoptotic cell death in tumor cells in the presence of the copper-iron nanocatalyst. Furthermore, we also provide a novel analytical protocol, alternative to state-of-the-art commercial kits, to accurately monitoring the concentration of GSH intracellular levels in both tumor and healthy cells. We observe a selective action of the nanoparticles, with lower toxicity in healthy cell lines, whose intrinsic GSH levels are lower, and intense apoptosis in tumor cells accompanied by a fast reduction of GSH levels.</dc:description><dc:date>2022</dc:date><dc:source>http://zaguan.unizar.es/record/117168</dc:source><dc:doi>10.1016/j.jcis.2022.03.036</dc:doi><dc:identifier>http://zaguan.unizar.es/record/117168</dc:identifier><dc:identifier>oai:zaguan.unizar.es:117168</dc:identifier><dc:relation>info:eu-repo/grantAgreement/EC/H2020/742684/EU/Catalytic Dual-Function Devices Against Cancer/CADENCE</dc:relation><dc:relation>This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 742684-CADENCE</dc:relation><dc:identifier.citation>Journal of Colloid and Interface Science 617 (2022), 704-717</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>